R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

From precision medicine to precision skin health: Verily and...

Verily, an Alphabet precision health tech company, and L’Oréal, a leading household name in beauty, have announced the launch of the ‘My Skin & Hair Journey’ – a multi-year study to ena

R&D

Oncology R&D hits new heights, but that creates problems

The number of people globally who are being treated for cancer is steadily going up each year.

R&D

The 4 must-have characteristics for finding the right patien...

The life sciences community is a powerful force determined to bring hope and healing to people around the world through relentless research and exploration.

R&D

Experts warn of superbug risks after Madonna’s hospitalisati...

The recent hospitalisation of Madonna once again highlights the risks posed by bacterial infections and their potentially serious consequences for patients.

Oncology

Molecular glues ‘combine best attributes’ of small and large...

As the industry has transitioned much of its R&D expertise into large molecule therapies, an emerging approach could provide a revolutionary treatment tool.

R&D